| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.896 | 0.003 | 0.896 | Hypolipemic | 0.877 0.003 DBMET01671 0.872 0.003 DBMET01672 0.877 0.003 DBMET00213 0.845 0.004 DBMET00214 0.872 0.003 DBMET00215 | ||
| 0.709 | 0.001 | 0.709 | HMG CoA reductase inhibitor | 0.593 0.001 DBMET01671 0.568 0.001 DBMET01672 0.593 0.001 DBMET00213 0.474 0.001 DBMET00214 0.568 0.001 DBMET00215 | ||
| 0.504 | 0.028 | 0.504 | Antithrombotic | 0.468 0.034 DBMET01671 0.502 0.029 DBMET01672 0.468 0.034 DBMET00213 0.48 0.032 DBMET00214 0.502 0.029 DBMET00215 | ||
| 0.482 | 0.016 | 0.503 | Platelet antagonist | 0.435 0.021 DBMET01671 0.435 0.021 DBMET01672 0.435 0.021 DBMET00213 0.503 0.014 DBMET00214 0.435 0.021 DBMET00215 | DBMET00214 | |
| 0.434 | 0.045 | 0.524 | Vasodilator, peripheral | 0.401 0.055 DBMET01671 0.42 0.049 DBMET01672 0.401 0.055 DBMET00213 0.524 0.024 DBMET00214 0.42 0.049 DBMET00215 | DBMET00214 | |
| 0.385 | 0.049 | 0.418 | 5 Hydroxytryptamine release stimulant | 0.304 0.069 DBMET01671 0.418 0.042 DBMET01672 0.304 0.069 DBMET00213 0.395 0.047 DBMET00214 0.418 0.042 DBMET00215 | DBMET00215 | |
| 0.419 | 0.105 | 0.462 | Apoptosis agonist | 0.462 0.087 DBMET01671 0.462 0.087 DBMET01672 0.462 0.087 DBMET00213 0.462 0.087 DBMET00215 | DBMET00215 | |
| 0.296 | 0.004 | 0.439 | Prostaglandin EP2 antagonist | 0.263 0.005 DBMET01671 0.254 0.005 DBMET01672 0.263 0.005 DBMET00213 0.439 0.004 DBMET00214 0.254 0.005 DBMET00215 | DBMET00214 | |
| 0.388 | 0.098 | 0.389 | Cyclophilin D inhibitor | 0.389 0.097 DBMET01671 0.381 0.102 DBMET01672 0.389 0.097 DBMET00213 0.297 0.166 DBMET00214 0.381 0.102 DBMET00215 | DBMET00213 | |
| 0.308 | 0.08 | 0.322 | Apoptosis antagonist | 0.322 0.071 DBMET01671 0.322 0.072 DBMET01672 0.322 0.071 DBMET00213 0.317 0.075 DBMET00214 0.322 0.072 DBMET00215 | DBMET00215 | |
| 0.264 | 0.069 | 0.277 | Interleukin agonist | 0.214 0.108 DBMET01671 0.235 0.091 DBMET01672 0.214 0.108 DBMET00213 0.277 0.06 DBMET00214 0.235 0.091 DBMET00215 | DBMET00214 | |
| 0.279 | 0.09 | 0.286 | Interleukin 2 agonist | 0.283 0.087 DBMET01671 0.286 0.084 DBMET01672 0.283 0.087 DBMET00213 0.272 0.096 DBMET00214 0.286 0.084 DBMET00215 | DBMET00215 | |
| 0.237 | 0.049 | 0.249 | Non-steroidal antiinflammatory agent | 0.225 0.054 DBMET01671 0.249 0.043 DBMET01672 0.225 0.054 DBMET00213 0.247 0.044 DBMET00214 0.249 0.043 DBMET00215 | DBMET00215 | |
| 0.192 | 0.004 | 0.231 | Prostaglandin F2 alpha antagonist | 0.168 0.004 DBMET01671 0.164 0.004 DBMET01672 0.168 0.004 DBMET00213 0.231 0.004 DBMET00214 0.164 0.004 DBMET00215 | DBMET00214 | |
| 0.22 | 0.034 | 0.281 | NOS3 expression enhancer | 0.24 0.029 DBMET01671 0.264 0.024 DBMET01672 0.24 0.029 DBMET00213 0.281 0.021 DBMET00214 0.264 0.024 DBMET00215 | DBMET00214 | |
| 0.199 | 0.034 | 0.199 | MAP kinase kinase 5 inhibitor | 0.199 0.034 DBMET01671 0.18 0.062 DBMET01672 0.199 0.034 DBMET00213 0.18 0.062 DBMET00215 | ||
| 0.173 | 0.009 | 0.182 | Prostaglandin antagonist | 0.126 0.013 DBMET01671 0.121 0.014 DBMET01672 0.126 0.013 DBMET00213 0.182 0.008 DBMET00214 0.121 0.014 DBMET00215 | DBMET00214 | |
| 0.178 | 0.02 | 0.199 | Catalase inhibitor | 0.132 0.03 DBMET01671 0.117 0.034 DBMET01672 0.132 0.03 DBMET00213 0.199 0.015 DBMET00214 0.117 0.034 DBMET00215 | DBMET00214 | |
| 0.194 | 0.037 | 0.227 | Bone formation stimulant | 0.227 0.029 DBMET01671 0.21 0.033 DBMET01672 0.227 0.029 DBMET00213 0.176 0.043 DBMET00214 0.21 0.033 DBMET00215 | DBMET00213 | |
| 0.179 | 0.025 | 0.213 | Interleukin 1b antagonist | 0.168 0.029 DBMET01671 0.162 0.032 DBMET01672 0.168 0.029 DBMET00213 0.213 0.017 DBMET00214 0.162 0.032 DBMET00215 | DBMET00214 | |
| 0.229 | 0.083 | 0.25 | Vasodilator | 0.242 0.074 DBMET01671 0.242 0.074 DBMET01672 0.242 0.074 DBMET00213 0.25 0.069 DBMET00214 0.242 0.074 DBMET00215 | DBMET00214 | |
| 0.177 | 0.033 | 0.228 | Cholesterol synthesis inhibitor | 0.19 0.029 DBMET01671 0.208 0.025 DBMET01672 0.19 0.029 DBMET00213 0.228 0.021 DBMET00214 0.208 0.025 DBMET00215 | DBMET00214 | |
| 0.207 | 0.066 | 0.264 | Insulin sensitizer | 0.215 0.059 DBMET01671 0.214 0.06 DBMET01672 0.215 0.059 DBMET00213 0.264 0.027 DBMET00214 0.214 0.06 DBMET00215 | DBMET00214 | |
| 0.123 | 0.005 | 0.157 | Prostaglandin EP3 antagonist | 0.096 0.006 DBMET01671 0.095 0.006 DBMET01672 0.096 0.006 DBMET00213 0.157 0.004 DBMET00214 0.095 0.006 DBMET00215 | DBMET00214 | |
| 0.136 | 0.022 | 0.136 | ABCA1 expression enhancer | 0.133 0.023 DBMET01671 0.131 0.024 DBMET01672 0.133 0.023 DBMET00213 0.101 0.049 DBMET00214 0.131 0.024 DBMET00215 | ||
| 0.154 | 0.055 | 0.205 | Interleukin 1 antagonist | 0.152 0.056 DBMET01671 0.146 0.06 DBMET01672 0.152 0.056 DBMET00213 0.205 0.031 DBMET00214 0.146 0.06 DBMET00215 | DBMET00214 | |
| 0.105 | 0.01 | 0.114 | Thromboxane antagonist | 0.089 0.015 DBMET01671 0.089 0.015 DBMET01672 0.089 0.015 DBMET00213 0.114 0.008 DBMET00214 0.089 0.015 DBMET00215 | DBMET00214 | |
| 0.098 | 0.008 | 0.106 | Thromboxane A2 antagonist | 0.083 0.013 DBMET01671 0.083 0.013 DBMET01672 0.083 0.013 DBMET00213 0.106 0.006 DBMET00214 0.083 0.013 DBMET00215 | DBMET00214 | |
| 0.125 | 0.039 | 0.136 | Toll-Like receptor 4 antagonist | 0.132 0.033 DBMET01671 0.136 0.03 DBMET01672 0.132 0.033 DBMET00213 0.118 0.046 DBMET00214 0.136 0.03 DBMET00215 | DBMET00215 | |
| 0.096 | 0.01 | 0.096 | Nitric oxide donor | 0.093 0.013 DBMET01671 0.092 0.013 DBMET01672 0.093 0.013 DBMET00213 0.082 0.02 DBMET00214 0.092 0.013 DBMET00215 | ||
| 0.107 | 0.031 | 0.134 | ATPase (Vacuolar H+) inhibitor | 0.109 0.028 DBMET01671 0.107 0.031 DBMET01672 0.109 0.028 DBMET00213 0.134 0.012 DBMET00214 0.107 0.031 DBMET00215 | DBMET00214 | |
| 0.08 | 0.005 | 0.08 | Prostaglandin EP4 antagonist | 0.043 0.01 DBMET01671 0.043 0.01 DBMET01672 0.043 0.01 DBMET00213 0.056 0.007 DBMET00214 0.043 0.01 DBMET00215 | ||
| 0.087 | 0.018 | 0.142 | Prostaglandin E2 antagonist | 0.065 0.026 DBMET01671 0.063 0.027 DBMET01672 0.065 0.026 DBMET00213 0.142 0.009 DBMET00214 0.063 0.027 DBMET00215 | DBMET00214 | |
| 0.064 | 0.005 | 0.068 | Prostaglandin D2 agonist | 0.059 0.005 DBMET01671 0.059 0.005 DBMET01672 0.059 0.005 DBMET00213 0.068 0.004 DBMET00214 0.059 0.005 DBMET00215 | DBMET00214 | |
| 0.062 | 0.004 | 0.077 | Prostacyclin agonist | 0.05 0.004 DBMET01671 0.048 0.004 DBMET01672 0.05 0.004 DBMET00213 0.077 0.004 DBMET00214 0.048 0.004 DBMET00215 | DBMET00214 | |
| 0.162 | 0.109 | 0.293 | Interleukin antagonist | 0.206 0.081 DBMET01671 0.199 0.085 DBMET01672 0.206 0.081 DBMET00213 0.293 0.049 DBMET00214 0.199 0.085 DBMET00215 | DBMET00214 | |
| 0.058 | 0.009 | 0.102 | Prostaglandin agonist | 0.045 0.012 DBMET01671 0.044 0.012 DBMET01672 0.045 0.012 DBMET00213 0.102 0.005 DBMET00214 0.044 0.012 DBMET00215 | DBMET00214 | |
| 0.069 | 0.02 | 0.082 | Leukotriene B4 antagonist | 0.077 0.016 DBMET01671 0.082 0.015 DBMET01672 0.077 0.016 DBMET00213 0.065 0.023 DBMET00214 0.082 0.015 DBMET00215 | DBMET00215 | |
| 0.075 | 0.035 | 0.089 | Leukotriene antagonist | 0.074 0.036 DBMET01671 0.084 0.029 DBMET01672 0.074 0.036 DBMET00213 0.089 0.027 DBMET00214 0.084 0.029 DBMET00215 | DBMET00214 | |
| 0.046 | 0.007 | 0.058 | Prostaglandin EP2 agonist | 0.037 0.01 DBMET01671 0.036 0.01 DBMET01672 0.037 0.01 DBMET00213 0.058 0.005 DBMET00214 0.036 0.01 DBMET00215 | DBMET00214 | |
| 0.202 | 0.163 | 0.234 | Cholesterol antagonist | 0.207 0.158 DBMET01671 0.229 0.141 DBMET01672 0.207 0.158 DBMET00213 0.234 0.137 DBMET00214 0.229 0.141 DBMET00215 | DBMET00214 | |
| 0.045 | 0.009 | 0.05 | Leukotriene B4 receptor 1 antagonist | 0.043 0.01 DBMET01671 0.044 0.009 DBMET01672 0.043 0.01 DBMET00213 0.05 0.007 DBMET00214 0.044 0.009 DBMET00215 | DBMET00214 | |
| 0.076 | 0.042 | 0.094 | HIV-1 integrase inhibitor | 0.094 0.028 DBMET01671 0.093 0.029 DBMET01672 0.094 0.028 DBMET00213 0.083 0.036 DBMET00214 0.093 0.029 DBMET00215 | DBMET00213 | |
| 0.131 | 0.098 | 0.174 | Thrombolytic | 0.129 0.1 DBMET01671 0.138 0.092 DBMET01672 0.129 0.1 DBMET00213 0.174 0.065 DBMET00214 0.138 0.092 DBMET00215 | DBMET00214 | |
| 0.04 | 0.007 | 0.073 | Prostaglandin E2 agonist | 0.031 0.01 DBMET01671 0.031 0.01 DBMET01672 0.031 0.01 DBMET00213 0.073 0.005 DBMET00214 0.031 0.01 DBMET00215 | DBMET00214 | |
| 0.099 | 0.067 | 0.116 | Folate antagonist | 0.094 0.077 DBMET01671 0.092 0.081 DBMET01672 0.094 0.077 DBMET00213 0.116 0.043 DBMET00214 0.092 0.081 DBMET00215 | DBMET00214 | |
| 0.084 | 0.053 | 0.092 | Thioredoxin reductase inhibitor | 0.084 0.052 DBMET01671 0.084 0.051 DBMET01672 0.084 0.052 DBMET00213 0.092 0.038 DBMET00214 0.084 0.051 DBMET00215 | DBMET00214 | |
| 0.144 | 0.113 | 0.19 | Platelet adhesion inhibitor | 0.15 0.106 DBMET01671 0.153 0.102 DBMET01672 0.15 0.106 DBMET00213 0.19 0.077 DBMET00214 0.153 0.102 DBMET00215 | DBMET00214 | |
| 0.034 | 0.007 | 0.04 | Prostaglandin EP4 agonist | 0.04 0.006 DBMET00214 | DBMET00214 | |
| 0.132 | 0.107 | 0.161 | Interferon gamma antagonist | 0.16 0.066 DBMET01671 0.157 0.07 DBMET01672 0.16 0.066 DBMET00213 0.161 0.065 DBMET00214 0.157 0.07 DBMET00215 | DBMET00214 | |
| 0.062 | 0.038 | 0.071 | Cathepsin E inhibitor | 0.058 0.044 DBMET01671 0.057 0.045 DBMET01672 0.058 0.044 DBMET00213 0.071 0.029 DBMET00214 0.057 0.045 DBMET00215 | DBMET00214 | |
| 0.027 | 0.011 | 0.027 | Leukotriene B4 receptor 2 antagonist | 0.027 0.011 DBMET01671 0.027 0.011 DBMET01672 0.027 0.011 DBMET00213 0.024 0.013 DBMET00214 0.027 0.011 DBMET00215 | ||
| 0.069 | 0.056 | 0.092 | Phospholipase D inhibitor | 0.092 0.02 DBMET00214 | DBMET00214 | |
| 0.104 | 0.093 | 0.185 | Amylase inhibitor | 0.153 0.063 DBMET01671 0.179 0.052 DBMET01672 0.153 0.063 DBMET00213 0.185 0.05 DBMET00214 0.179 0.052 DBMET00215 | DBMET00214 | |
| 0.052 | 0.042 | 0.058 | Thromboxane synthase inhibitor | 0.058 0.031 DBMET00214 | DBMET00214 | |
| 0.02 | 0.02 | 0.027 | Prostaglandin F2 alpha agonist | 0.021 0.019 DBMET01671 0.021 0.019 DBMET00213 0.027 0.011 DBMET00214 | DBMET00214 | |
| 0.141 | 0.141 | 0.233 | Platelet aggregation inhibitor | 0.164 0.113 DBMET01671 0.164 0.113 DBMET00213 0.233 0.06 DBMET00214 | DBMET00214 | |
| 0.028 | 0.029 | 0.047 | Prostacyclin antagonist | 0.047 0.014 DBMET00214 | DBMET00214 | |
| 0.015 | 0.018 | 0.027 | Prostaglandin EP1 antagonist | 0.027 0.011 DBMET00214 | DBMET00214 | |
| 0.159 | 0.163 | 0.198 | Hypoglycemic | 0.196 0.116 DBMET01671 0.193 0.12 DBMET01672 0.196 0.116 DBMET00213 0.198 0.114 DBMET00214 0.193 0.12 DBMET00215 | DBMET00214 | |
| 0.079 | 0.084 | 0.121 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.121 0.038 DBMET00214 | DBMET00214 | |
| 0.057 | 0.062 | 0.117 | Phenylalanine 4-hydroxylase inhibitor | 0.067 0.049 DBMET01671 0.063 0.053 DBMET01672 0.067 0.049 DBMET00213 0.117 0.019 DBMET00214 0.063 0.053 DBMET00215 | DBMET00214 | |
| 0.023 | 0.031 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.021 DBMET00214 | DBMET00214 | |
| 0.128 | 0.138 | 0.156 | Hepatoprotectant | 0.15 0.11 DBMET01671 0.156 0.104 DBMET01672 0.15 0.11 DBMET00213 0.152 0.108 DBMET00214 0.156 0.104 DBMET00215 | DBMET00215 | |
| 0.041 | 0.058 | 0.063 | Aconitate hydratase inhibitor | 0.063 0.023 DBMET00214 | DBMET00214 | |
| 0.024 | 0.042 | 0.03 | ATP citrate lysase inhibitor | 0.03 0.024 DBMET01671 0.029 0.027 DBMET01672 0.03 0.024 DBMET00213 0.029 0.027 DBMET00215 | DBMET00213 | |
| 0.09 | 0.111 | 0.11 | Microtubule formation inhibitor | 0.11 0.074 DBMET00214 | DBMET00214 | |
| 0.05 | 0.076 | 0.058 | Caspase 9 inhibitor | 0.058 0.052 DBMET00214 | DBMET00214 | |
| 0.081 | 0.106 | 0.295 | Adenylate cyclase inhibitor | 0.295 0.014 DBMET00214 | DBMET00214 | |
| 0.117 | 0.143 | 0.155 | Melanin inhibitor | 0.147 0.086 DBMET01671 0.155 0.075 DBMET01672 0.147 0.086 DBMET00213 0.134 0.107 DBMET00214 0.155 0.075 DBMET00215 | DBMET00215 | |
| 0.077 | 0.103 | 0.149 | Ferrochelatase inhibitor | 0.149 0.038 DBMET00214 | DBMET00214 | |
| 0.037 | 0.064 | 0.048 | Glucose-6-phosphate isomerase inhibitor | 0.048 0.033 DBMET00214 | DBMET00214 | |
| 0.009 | 0.038 | 0.015 | Thromboxane A2 agonist | 0.015 0.012 DBMET00214 | DBMET00214 | |
| 0.141 | 0.171 | 0.189 | Tumour necrosis factor alpha release inhibitor | 0.163 0.142 DBMET01672 0.189 0.119 DBMET00214 0.163 0.142 DBMET00215 | DBMET00214 | |
| 0.104 | 0.137 | 0.119 | Papain-like protease (SARS coronavirus) inhibitor | 0.119 0.085 DBMET01671 0.119 0.084 DBMET01672 0.119 0.085 DBMET00213 0.119 0.084 DBMET00215 | DBMET00215 | |
| 0.113 | 0.149 | 0.143 | Nitric oxide antagonist | 0.139 0.107 DBMET01671 0.143 0.102 DBMET01672 0.139 0.107 DBMET00213 0.143 0.102 DBMET00215 | DBMET00215 | |
| 0.068 | 0.105 | 0.101 | Triose-phosphate isomerase inhibitor | 0.101 0.047 DBMET00214 | DBMET00214 | |
| 0.122 | 0.16 | 0.155 | Lipocortins synthesis antagonist | 0.155 0.098 DBMET00214 | DBMET00214 | |
| 0.033 | 0.072 | 0.044 | Plasminogen activator inhibitor antagonist | 0.044 0.041 DBMET00214 | DBMET00214 | |
| 0.053 | 0.093 | 0.068 | Glutamate dehydrogenase inhibitor | 0.068 0.06 DBMET00214 | DBMET00214 | |
| 0.126 | 0.166 | 0.155 | Succinate dehydrogenase inhibitor | 0.155 0.103 DBMET00214 | DBMET00214 | |
| 0.038 | 0.082 | 0.054 | Carbamoyl phosphate synthetase inhibitor | 0.054 0.049 DBMET00214 | DBMET00214 | |
| 0.023 | 0.067 | 0.036 | Estrogen-related receptor beta antagonist | 0.031 0.026 DBMET01671 0.036 0.016 DBMET01672 0.031 0.026 DBMET00213 0.036 0.016 DBMET00215 | DBMET00215 | |
| 0.077 | 0.123 | 0.096 | Phosphodiesterase 6D inhibitor | 0.096 0.061 DBMET00214 | DBMET00214 | |
| 0.048 | 0.096 | 0.073 | Glutamate decarboxylase inhibitor | 0.07 0.055 DBMET01671 0.07 0.055 DBMET00213 0.073 0.051 DBMET00214 | DBMET00214 | |
| 0.103 | 0.154 | 0.133 | Growth hormone agonist | 0.133 0.103 DBMET00214 | DBMET00214 | |
| 0.101 | 0.158 | 0.169 | Angiogenesis stimulant | 0.135 0.133 DBMET01671 0.145 0.126 DBMET01672 0.135 0.133 DBMET00213 0.169 0.111 DBMET00214 0.145 0.126 DBMET00215 | DBMET00214 | |
| 0.083 | 0.142 | 0.129 | Toll-Like receptor 2 antagonist | 0.12 0.078 DBMET01672 0.129 0.069 DBMET00214 0.12 0.078 DBMET00215 | DBMET00214 | |
| 0.23 | 0.29 | 0.276 | Antiinflammatory | 0.276 0.238 DBMET01672 0.276 0.238 DBMET00215 | DBMET00215 | |
| 0.035 | 0.1 | 0.061 | Phosphofructokinase-1 inhibitor | 0.061 0.055 DBMET00214 | DBMET00214 | |
| 0.157 | 0.235 | 0.223 | Tyrosine 3 hydroxylase inhibitor | 0.223 0.099 DBMET00214 | DBMET00214 | |
| 0.113 | 0.193 | 0.199 | ATPase inhibitor | 0.199 0.038 DBMET00214 | DBMET00214 | |
| 0.147 | 0.231 | 0.253 | Transcription factor NF kappa B inhibitor | 0.224 0.147 DBMET01671 0.232 0.141 DBMET01672 0.224 0.147 DBMET00213 0.253 0.125 DBMET00214 0.232 0.141 DBMET00215 | DBMET00214 | |
| 0.067 | 0.158 | 0.086 | Glutamate release inhibitor | 0.086 0.071 DBMET00214 | DBMET00214 | |
| 0.108 | 0.205 | 0.17 | Immunostimulant | 0.17 0.139 DBMET00214 | DBMET00214 | |
| 0.154 | 0.261 | 0.229 | Sodium/bile acid cotransporter inhibitor | 0.211 0.174 DBMET01671 0.229 0.151 DBMET01672 0.211 0.174 DBMET00213 0.229 0.151 DBMET00215 | DBMET00215 | |
| 0.093 | 0.205 | 0.136 | Adenylate cyclase stimulant | 0.136 0.089 DBMET00214 | DBMET00214 | |
| 0.065 | 0.185 | 0.1 | Adenylate kinase inhibitor | 0.1 0.067 DBMET00214 | DBMET00214 | |
| 0.067 | 0.188 | 0.108 | Photosensitizer | 0.108 0.075 DBMET00214 | DBMET00214 | |
| 0.101 | 0.236 | 0.137 | MAP kinase kinase 4 inhibitor | 0.137 0.092 DBMET00214 | DBMET00214 | |
| 0.136 | 0.276 | 0.22 | Immunosuppressant | 0.22 0.176 DBMET00214 | DBMET00214 | |
| 0.068 | 0.221 | 0.135 | Interleukin 8 antagonist | 0.135 0.046 DBMET00214 | DBMET00214 | |
| 0.04 | 0.215 | 0.083 | Creatine kinase inhibitor | 0.083 0.081 DBMET01671 0.083 0.081 DBMET00213 | DBMET00213 | |
| 0.033 | 0.217 | 0.075 | Glycine receptor antagonist | 0.075 0.065 DBMET00214 | DBMET00214 | |
| 0.01 | 0.199 | 0.05 | Phosphorylase inhibitor | 0.05 0.03 DBMET00214 | DBMET00214 | |
| 0.041 | 0.232 | 0.099 | GABA C receptor agonist | 0.099 0.067 DBMET00214 | DBMET00214 | |
| 0.045 | 0.241 | 0.132 | AMP-activated protein kinase stimulant | 0.132 0.04 DBMET00214 | DBMET00214 | |
| 0.107 | 0.304 | 0.204 | Gastrin inhibitor | 0.204 0.143 DBMET00214 | DBMET00214 | |
| 0.058 | 0.265 | 0.144 | Pyruvate kinase inhibitor | 0.144 0.12 DBMET00214 | DBMET00214 | |
| 0.081 | 0.302 | 0.165 | Antioxidant | 0.165 0.147 DBMET01672 0.165 0.147 DBMET00215 | DBMET00215 | |
| 0.091 | 0.347 | 0.177 | Catenin beta inhibitor | 0.177 0.056 DBMET00214 | DBMET00214 | |
| 0.021 | 0.378 | 0.102 | Histone deacetylase SIRT1 stimulant | 0.102 0.027 DBMET00214 | DBMET00214 | |
| 0.021 | 0.378 | 0.102 | Histone deacetylase stimulant | 0.102 0.027 DBMET00214 | DBMET00214 | |
| 0.031 | 0.443 | 0.101 | Estrogen antagonist | 0.101 0.097 DBMET01672 0.101 0.097 DBMET00215 | DBMET00215 | |
| 0.042 | 0.605 | 0.326 | Toll-Like receptor agonist | 0.326 0.095 DBMET00214 | DBMET00214 | |
| 0.037 | 0.635 | 0.294 | Toll-Like receptor 7 agonist | 0.294 0.114 DBMET00214 | DBMET00214 | |
| 0.004 | 0.887 | 0.056 | Phosphodiesterase VII inhibitor | 0.056 0.052 DBMET00214 | DBMET00214 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |